+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

USA Antibody Drug Conjugates Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

USA Antibody Drug Conjugates Market - Forecasts from 2022 to 2027

  • Report
  • April 2022
  • 80 Pages
  • United States
From
From
From
From
Pompe Disease Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Pompe Disease Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Cytomegalovirus (CMV) Infection - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cytomegalovirus (CMV) Infection - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Urology Devices Market Report 2025 - Product Thumbnail Image

Urology Devices Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Oncolytic Virus - Competitive Landscape, 2022 - Product Thumbnail Image

Oncolytic Virus - Competitive Landscape, 2022

  • Report
  • October 2022
  • 300 Pages
  • Global
From
Gene Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gene Therapy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Loading Indicator